Therapeutic Processes and Treatment Outcome in Adolescents With Anxiety Disorders

This study has been completed.

First Received: October 29, 2003 Last Updated: September 19, 2008 History of Changes

Sponsored by:	National Institute of Mental Health (NIMH)
Information provided by:	National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:	NCT00071630

Purpose

The purpose of this study is to examine the relationship between different aspects of cognitive behavior therapy (CBT) and treatment outcome.

Condition	Intervention	Phase
Anxiety Disorders	Behavioral: Cognitive Behavioral Therapy	Phase IV

MedlinePlus related topics: Anxiety

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Official Title:	Process as a Predictor of Outcomes in CBT for Youth

Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment:	130
Study Start Date:	September 2002
Estimated Study Completion Date:	August 2005

Detailed Description:

Anxiety disorders are common among children; if untreated, they can negatively affect children's lives. Evidence suggests that CBT can benefit children with anxiety disorders, but the causal mechanisms between therapy and beneficial outcomes have not been thoroughly investigated.

Audio and videotaped sessions of children currently receiving CBT and those who received CBT in previous trials will be examined. Various rating scales will be used to rate therapeutic alliance, child involvement, and therapist flexibility for each session of CBT. To evaluate potential process variables that contribute to participant drop-out, this study will compare the early process variables for children who complete treatment and for those who discontinue treatment.

Eligibility

Ages Eligible for Study:	8 Years to 13 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion criteria:

Diagnosis of separation anxiety disorder, generalized anxiety disorder, or social phobia
At least one English-speaking parent

Exclusion criteria:

IQ < 80
Psychotic symptoms

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00071630

Locations

United States, Pennsylvania
Temple University
Philadelphia, Pennsylvania, United States, 19122
Australia, New South Wales
Macquarie University
Sydney, New South Wales, Australia, 2109

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

More Information

Additional Information:

Child and Adolescent Anxiety Disorders Clinic homepage This link exits the ClinicalTrials.gov site

No publications provided

Study ID Numbers:	R01 MH64484, DSIR CT-S
Study First Received:	October 29, 2003
Last Updated:	September 19, 2008
ClinicalTrials.gov Identifier:	NCT00071630 History of Changes
Health Authority:	United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):

Adolescent

Study placed in the following topic categories:

Anxiety Disorders
Mental Disorders

Additional relevant MeSH terms:

Pathologic Processes
Disease
Anxiety Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 07, 2009